Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations.

[1]  Carl J Pepine,et al.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.

[2]  S. Kathiresan,et al.  A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. , 2002, Journal of the American College of Cardiology.

[3]  M. Simoons,et al.  Minor Myocardial Damage and Prognosis: Are Spontaneous and Percutaneous Coronary Intervention–Related Events Different? , 2002, Circulation.

[4]  R. Califf,et al.  Opportunities for Enhancing the Use of Evidence-Based Medicines for Acute Coronary Syndromes: Insights From the Symphony Studies , 2002 .

[5]  L. Wallentin,et al.  Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. , 2002, Journal of the American College of Cardiology.

[6]  A. Yeung,et al.  Prevention of Distal Embolization During Coronary Angioplasty in Saphenous Vein Grafts and Native Vessels Using Porous Filter Protection , 2001, Circulation.

[7]  E. Antman.  Troponin measurements in ischemic heart disease: more than just a black and white picture. , 2001, Journal of the American College of Cardiology.

[8]  B. Chaitman,et al.  Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial. , 2001, Journal of the American College of Cardiology.

[9]  S. Wagenpfeil,et al.  Predictive value of perioperative cardiac troponin I for adverse outcome in coronary artery bypass surgery. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  S. Yusuf,et al.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. , 2001, The New England journal of medicine.

[11]  R. Califf,et al.  Systematic adjudication of myocardial infarction end-points in an international clinical trial , 2001, Current controlled trials in cardiovascular medicine.

[12]  E. Braunwald,et al.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. , 2001, The New England journal of medicine.

[13]  V. Hasselblad,et al.  Benefit of Glycoprotein IIb/IIIa Inhibition in Patients With Acute Coronary Syndromes and Troponin T–Positive Status: The PARAGON-B Troponin T Substudy , 2001, Circulation.

[14]  M. Simoons.  Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial , 2001, The Lancet.

[15]  J. Alpert,et al.  Redefinition of myocardial infarction by a consensus dissenter: reply , 2001 .

[16]  H. Tunstall-Pedoe.  Redefinition of myocardial infarction by a consensus dissenter. , 2001, Journal of the American College of Cardiology.

[17]  R. Fitzgerald,et al.  Usefulness of cardiac troponin I in patients undergoing open heart surgery. , 2001, American heart journal.

[18]  A. Wu,et al.  International survey on the use of cardiac markers. , 2001, Clinical chemistry.

[19]  J. Alpert,et al.  Cardiac enzyme elevations after cardiac surgery: the cardiologist's perspective. , 2001, American heart journal.

[20]  M. Volmer,et al.  Creatine kinase MB, troponin I, and troponin T release patterns after coronary artery bypass grafting with or without cardiopulmonary bypass and after aortic and mitral valve surgery. , 2001, Clinical chemistry.

[21]  G. Wells,et al.  Cardiac troponin T predicts long-term outcomes in hemodialysis patients. , 2001, Clinical chemistry.

[22]  A. Wu,et al.  Myocardial infarction redefined: role of cardiac troponin testing. , 2001, Clinical chemistry.

[23]  Grace Investigators,et al.  Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. , 2001, American heart journal.

[24]  K. Kataoka,et al.  Persistently Increased Serum Concentrations of Cardiac Troponin T in Patients With Idiopathic Dilated Cardiomyopathy Are Predictive of Adverse Outcomes , 2001, Circulation.

[25]  A. Goetz,et al.  Markers of myocardial ischemia after minimally invasive and conventional coronary operation. , 2000, The Annals of thoracic surgery.

[26]  A. Jaffe,et al.  Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. , 2000, American heart journal.

[27]  D. Loisance,et al.  Cardiac troponin I release after open heart surgery: a marker of myocardial protection? , 2000, The Annals of thoracic surgery.

[28]  C. Luley,et al.  Cardiac Troponin T Predicts Mortality in Patients With End-Stage Renal Disease , 2000, Circulation.

[29]  J. Frederiksen,et al.  Postoperative troponin I values: Insult or injury? , 2000, Clinical cardiology.

[30]  J S Alpert,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, Journal of the American College of Cardiology.

[31]  T. Bowker,et al.  Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK) , 2000, European heart journal.

[32]  U Keil,et al.  The ENACT study: a pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment. , 2000, European heart journal.

[33]  J. W. Schaeffer,et al.  ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina) , 2000 .

[34]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[35]  G. Specchia,et al.  Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. , 2000, European heart journal.

[36]  G. Stone,et al.  Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions. , 2000, The American journal of cardiology.

[37]  R. Califf,et al.  Comparison of cardiac troponin T versus creatine kinase-MB for risk stratification in a chest pain evaluation unit. , 2000, The American journal of cardiology.

[38]  G. Stone,et al.  Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting. , 2000, Journal of the American College of Cardiology.

[39]  E. Topol,et al.  Recognition of the importance of embolization in atherosclerotic vascular disease. , 2000, Circulation.

[40]  M. Carrier,et al.  Troponin levels in patients with myocardial infarction after coronary artery bypass grafting. , 2000, The Annals of thoracic surgery.

[41]  S. Braun,et al.  Plasma troponin T and troponin I after minimally invasive coronary bypass surgery. , 2000, Clinical chemistry.

[42]  R. Califf,et al.  Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial , 2000, The Lancet.

[43]  R. Califf,et al.  Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. , 2000, JAMA.

[44]  L Matis,et al.  Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass. , 1999, Circulation.

[45]  O. Colak,et al.  Measurement of troponin T to detect cardioprotective effect of trimetazidine during coronary artery bypass grafting. , 1999, The Annals of thoracic surgery.

[46]  H. White,et al.  Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban , 1999, The Lancet.

[47]  P. D. de Feyter,et al.  Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and MUSIC trials. Multicenter Ultrasound Stent In Coro , 1999, Journal of the American College of Cardiology.

[48]  H. Helenius,et al.  Epidemiological classification of acute myocardial infarction: time for a change? , 1999, European heart journal.

[49]  A. Bochenek,et al.  Cardiac troponin T release during coronary surgery using intermittent cross-clamp with fibrillation, on-pump and off-pump beating heart. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[50]  H. Gutermann,et al.  Release of cardiac troponin I in antegrade crystalloid versus cold blood cardioplegia. , 1999, The Journal of thoracic and cardiovascular surgery.

[51]  A. Ghini,et al.  Beneficial impact of isoflurane during coronary bypass surgery on troponin I release. , 1999, Giornale italiano di cardiologia.

[52]  L. Wallentin,et al.  Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999, The Lancet.

[53]  F. Ragmin.  Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999, The Lancet.

[54]  P. Teirstein,et al.  Retrieval and analysis of particulate debris after saphenous vein graft intervention. , 1999, Journal of the American College of Cardiology.

[55]  R. Fitzgerald,et al.  A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a Veteran's Hospital: a pilot study. , 1999, Journal of the American College of Cardiology.

[56]  R. Califf,et al.  Minimal myocardial damage during coronary intervention is associated with impaired outcome. , 1999, European heart journal.

[57]  P. Fabbro-Péray,et al.  Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. , 1999, The American journal of cardiology.

[58]  J. Ferrières,et al.  Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the "real world": one-year results from a nationwide French survey. , 1999, Circulation.

[59]  P. Rahko,et al.  Adenosine myocardial protection: preliminary results of a phase II clinical trial. , 1999, Annals of surgery.

[60]  J. Pepper,et al.  Intraoperative cardiac troponin T release and lactate metabolism during coronary artery surgery: comparison of beating heart with conventional coronary artery surgery with cardiopulmonary bypass , 1999, Heart.

[61]  R. Califf,et al.  Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention , 1999 .

[62]  L. Wallentin,et al.  Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999 .

[63]  A. Siegbahn,et al.  Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators. , 1999, Lancet.

[64]  R. Abbate,et al.  Cardiac troponin I and Q-wave perioperative myocardial infarction after coronary artery bypass surgery. , 1998, Critical care medicine.

[65]  J. T. Barron.  Cardiac troponin I and non-Q-wave myocardial infarction: how useful is it after coronary artery bypass surgery? , 1998, Critical care medicine.

[66]  K. Lee,et al.  Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. , 1998, Circulation.

[67]  J. Pepper,et al.  Intraoperative release of troponin T in coronary venous and arterial blood and its relation to recovery of left ventricular function and oxidative metabolism following coronary artery surgery , 1998, Heart.

[68]  C. Heeschen,et al.  Analytical performance and clinical application of a new rapid bedside assay for the detection of serum cardiac troponin I. , 1998, Clinical chemistry.

[69]  P. Touboul,et al.  Troponin I, troponin T, or creatine kinase-MB to detect perioperative myocardial damage after coronary artery bypass surgery. , 1998, Chest.

[70]  T. Investigators.  Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. , 1998, Lancet.

[71]  E. Topol.  Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade , 1998, The Lancet.

[72]  B. Becker,et al.  Cardiac troponin-I accurately predicts myocardial injury in renal failure. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[73]  D. Chatel,et al.  Cardiac troponin I in diagnosis of perioperative myocardial infarction after cardiac surgery. , 1998, Journal of cardiothoracic and vascular anesthesia.

[74]  K. Shyu,et al.  Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting. , 1998, American heart journal.

[75]  P. Noirhomme,et al.  Cardiac troponin I as an early marker of myocardial damage after coronary bypass surgery. , 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[76]  R. Califf,et al.  Myonecrosis after revascularization procedures. , 1998, Journal of the American College of Cardiology.

[77]  H. Arnesen,et al.  Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measurements. , 1998, European heart journal.

[78]  H. Arnesen,et al.  Markers of myocardial injury in blood following PTCA: a comparison of CKMB, cardiospecific troponin T and troponin I. , 1998, Scandinavian journal of clinical and laboratory investigation.

[79]  T. Etgen,et al.  Cardiac troponin I plasma levels for diagnosis and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery. , 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[80]  C. Heeschen,et al.  Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. , 1997, The New England journal of medicine.

[81]  I. Birdi,et al.  Troponin I release during minimally invasive coronary artery surgery. , 1997, The Journal of thoracic and cardiovascular surgery.

[82]  R. Califf,et al.  A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. , 1997 .

[83]  D Kromhout,et al.  The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. , 1997, European heart journal.

[84]  M. Simoons,et al.  A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. , 1997, The New England journal of medicine.

[85]  Epilog Investigators,et al.  Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. , 1997, The New England journal of medicine.

[86]  Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II.  Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II , 1997, The Lancet.

[87]  Stgrp Capture,et al.  Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study , 1997, The Lancet.

[88]  W. Leowattana,et al.  Cardiac troponin T concentration after coronary balloon angioplasty. , 1997, The American journal of cardiology.

[89]  F. Apple,et al.  Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: a 1-year outcomes analysis. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[90]  Ohman Em,et al.  Periprocedural cardiac marker elevation after percutaneous coronary artery revascularization. Importance and implications. , 1997 .

[91]  R. Bonow,et al.  Prognostic implication of creatine kinase elevation following elective coronary artery interventions. , 1997, JAMA.

[92]  L. Wallentin,et al.  Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. , 1997, Journal of the American College of Cardiology.

[93]  F. Harrell,et al.  Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia , 1996 .

[94]  D Wybenga,et al.  Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. , 1996, The New England journal of medicine.

[95]  E. Topol,et al.  Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. , 1996, Circulation.

[96]  F. Bedogni,et al.  Troponin T, troponin I and creatine kinase‐MB mass after elective coronary stenting , 1996, Coronary artery disease.

[97]  J. Mair,et al.  Uncomplicated successful percutaneous transluminal coronary angioplasty does not affect cardiac troponin T plasma concentrations. , 1996, The American journal of cardiology.

[98]  J. Windle,et al.  Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty. , 1995, The American journal of cardiology.

[99]  G. Mayer,et al.  Lower cardiac troponin T levels in patients undergoing cardiopulmonary bypass and receiving high-dose aprotinin therapy indicate reduction of perioperative myocardial damage. , 1995, The Journal of thoracic and cardiovascular surgery.

[100]  R. Califf,et al.  Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). , 1995, Journal of the American College of Cardiology.

[101]  G. Toubin,et al.  Use of cardiac troponin I as a marker of perioperative myocardial ischemia. , 1995, The Annals of thoracic surgery.

[102]  Epic Investigators,et al.  Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. , 1994, The New England journal of medicine.

[103]  J. Ravkilde,et al.  Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. , 1994, American heart journal.

[104]  D. Baim,et al.  Defining coronary restenosis. Newer clinical and angiographic paradigms. , 1993, Circulation.

[105]  B. Cummins,et al.  Release of creatine kinase-MB and cardiac specific troponin-I following percutaneous transluminal coronary angioplasty. , 1991, European heart journal.

[106]  S. Khuri,et al.  Perioperative myocardial infarction after coronary artery bypass surgery. Clinical significance and approach to risk stratification. , 1990, Circulation.

[107]  Principal Investigators,et al.  The World Health Organization MONICA project (monitoring trends and determinants in cardiovascular disease): a major international collabaration , 1988 .

[108]  H. Tunstall-Pedoe,et al.  The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration , 1988 .

[109]  M. Kornitzer,et al.  The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): A major international Collaboration , 1988 .

[110]  B. Gersh,et al.  Detrimental effect of perioperative myocardial infarction on late survival after coronary artery bypass. Report from the Coronary Artery Surgery Study--CASS. , 1984, The Journal of thoracic and cardiovascular surgery.

[111]  L. T. Sheffield,et al.  Use of Survival Analysis to Determine the Clinical Significance of New Q Waves After Coronary Bypass Surgery , 1983, Circulation.

[112]  L D Fisher,et al.  Clinical and Angiographic Predictors of Operative Mortality from the Collaborative Study in Coronary Artery Surgery (CASS) , 1981, Circulation.

[113]  A. Pick,et al.  Direct radioimmunoassay with capillary chromatography tubes. , 1979, Clinical chemistry.

[114]  P. Thompson,et al.  Enzymatic Indices of Myocardial Necrosis: Influence on Short- and Long-Term Prognosis After Myocardial Infarction , 1979, Circulation.

[115]  G. Wagner,et al.  Diagnostic and prognostic significance of electrocardiographic and CPK isoenzyme changes following coronary bypass surgery: correlation with findings at one year. , 1977, American heart journal.

[116]  J. Ross,et al.  Detection of Perioperative Myocardial Damage after Coronary Artery Bypass Graft Surgery , 1977, Circulation.

[117]  K. B. Larson,et al.  Estimation of infarct size from serum MB creatine phosphokinase activity: Applications and limitations. , 1976, The American journal of cardiology.

[118]  G. Wagner,et al.  Recognition of Postoperative Acute Myocardial Infarction: Application of Isoenzyme Techniques , 1973, Circulation.

[119]  A. Bartel,et al.  Myocardial Infarction as a Complication of Coronary Bypass Surgery , 1973, Circulation.

[120]  B. Sobel,et al.  Estimation of Infarct Size in Man and its Relation to Prognosis , 1972, Circulation.

[121]  D. Sabiston,et al.  Postoperative myocardial infarction: a study of predisposing factors, diagnosis and mortality in a high risk group of surgical patients. , 1970, Annals of surgery.

[122]  A. Driscoll,et al.  CLINICALLY UNRECOGNIZED MYOCARDIAL INFARCTION FOLLOWING SURGERY , 1961, The New England journal of medicine.